These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20571209)

  • 21. Calibration of a mosfet detection system for 6-MV in vivo dosimetry.
    Scalchi P; Francescon P
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):987-93. PubMed ID: 9531385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An in vivo dose verification method for SBRT-VMAT delivery using the EPID.
    McCowan PM; Van Uytven E; Van Beek T; Asuni G; McCurdy BM
    Med Phys; 2015 Dec; 42(12):6955-63. PubMed ID: 26632051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of commercial MOSFET detectors for in vivo dosimetry in the therapeutic x-ray range from 80 kV to 250 kV.
    Ehringfeld C; Schmid S; Poljanc K; Kirisits C; Aiginger H; Georg D
    Phys Med Biol; 2005 Jan; 50(2):289-303. PubMed ID: 15742945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical experience with EPID dosimetry for prostate IMRT pre-treatment dose verification.
    McDermott LN; Wendling M; van Asselen B; Stroom J; Sonke JJ; van Herk M; Mijnheer BJ
    Med Phys; 2006 Oct; 33(10):3921-30. PubMed ID: 17089854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics and performance of a micro-MOSFET: an "imageable" dosimeter for image-guided radiotherapy.
    Rowbottoma CG; Jaffray DA
    Med Phys; 2004 Mar; 31(3):609-15. PubMed ID: 15070261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance characteristics of a microMOSFET as an in vivo dosimeter in radiation therapy.
    Ramaseshan R; Kohli KS; Zhang TJ; Lam T; Norlinger B; Hallil A; Islam M
    Phys Med Biol; 2004 Sep; 49(17):4031-48. PubMed ID: 15470921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MOSFET dosimeter characterization in MR-guided radiation therapy (MRgRT) Linac.
    Yadav P; Hallil A; Tewatia D; Dunkerley DAP; Paliwal B
    J Appl Clin Med Phys; 2020 Jan; 21(1):127-135. PubMed ID: 31854078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Online adaptation and verification of VMAT.
    Crijns W; Defraene G; Van Herck H; Depuydt T; Haustermans K; Maes F; Van den Heuvel F
    Med Phys; 2015 Jul; 42(7):3877-91. PubMed ID: 26133589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The angular dependence of a 2-dimensional diode array and the feasibility of its application in verifying the composite dose distribution of intensity-modulated radiation therapy.
    Li QL; Deng XW; Chen LX; Huang XY; Huang SM
    Chin J Cancer; 2010 Jun; 29(6):617-20. PubMed ID: 20507735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of a new MOSFET detector configuration for in vivo skin dosimetry.
    Scalchi P; Francescon P; Rajaguru P
    Med Phys; 2005 Jun; 32(6):1571-8. PubMed ID: 16013716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimization of skin dose using in-vivo MOSFET dose measurements in bolus/non-bolus fraction ratio: A VMAT and a 3DCRT study.
    Dias AG; Pinto DFS; Borges MF; Pereira MH; Santos JAM; Cunha LT; Lencart J
    J Appl Clin Med Phys; 2019 Feb; 20(2):63-70. PubMed ID: 30628154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of intensity-modulated radiotherapy and forward-planning dynamic arc therapy techniques for prostate cancer.
    Metwaly M; Awaad AM; El-Sayed EM; Sallam ASM
    J Appl Clin Med Phys; 2008 Oct; 9(4):37-56. PubMed ID: 19020481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feasibility study of a dual detector configuration concept for simultaneous megavoltage imaging and dose verification in radiotherapy.
    Deshpande S; McNamara AL; Holloway L; Metcalfe P; Vial P
    Med Phys; 2015 Apr; 42(4):1753-64. PubMed ID: 25832065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo and phantom measurements of the secondary photon and neutron doses for prostate patients undergoing 18 MV IMRT.
    Reft CS; Runkel-Muller R; Myrianthopoulos L
    Med Phys; 2006 Oct; 33(10):3734-42. PubMed ID: 17089839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modelling the variation in rectal dose due to inter-fraction rectal wall deformation in external beam prostate treatments.
    Booth J; Zavgorodni S
    Phys Med Biol; 2005 Nov; 50(21):5055-74. PubMed ID: 16237241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Verification of eye lens dose in IMRT by MOSFET measurement.
    Wang X; Li G; Zhao J; Song Y; Xiao J; Bai S
    Med Dosim; 2019 Summer; 44(2):107-110. PubMed ID: 29678482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proton dose distribution measurements using a MOSFET detector with a simple dose-weighted correction method for LET effects.
    Kohno R; Hotta K; Matsuura T; Matsubara K; Nishioka S; Nishio T; Kawashima M; Ogino T
    J Appl Clin Med Phys; 2011 Apr; 12(2):3431. PubMed ID: 21587191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct tumor in vivo dosimetry in highly-conformal radiotherapy: a feasibility study of implantable MOSFETs for hypofractionated extracranial treatments using the Cyberknife system.
    Scalchi P; Righetto R; Cavedon C; Francescon P; Colombo F
    Med Phys; 2010 Apr; 37(4):1413-23. PubMed ID: 20443463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Real-time in vivo dosimetry system based on an optical fiber-coupled microsized photostimulable phosphor for stereotactic body radiation therapy.
    Yada R; Maenaka K; Miyamoto S; Okada G; Sasakura A; Ashida M; Adachi M; Sato T; Wang T; Akasaka H; Mukumoto N; Shimizu Y; Sasaki R
    Med Phys; 2020 Oct; 47(10):5235-5249. PubMed ID: 32654194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment planning comparison of IMPT, VMAT and 4π radiotherapy for prostate cases.
    Tran A; Zhang J; Woods K; Yu V; Nguyen D; Gustafson G; Rosen L; Sheng K
    Radiat Oncol; 2017 Jan; 12(1):10. PubMed ID: 28077128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.